These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39098543)

  • 1. Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study.
    Zare P; Poustchi H; Mohammadi Z; Mesgarpour B; Akbari M; Kamalipour A; Abdipour-Mehrian SR; Hashemi ES; Ghamar-Shooshtari A; Hosseini SA; Malekzadeh R; Bazrafshan Drissi H; Malekzadeh F; Molavi Vardanjani H
    Res Social Adm Pharm; 2024 Nov; 20(11):1038-1046. PubMed ID: 39098543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran.
    Mohsenzadeh P; Ardekani A; Poustchi H; Mohammadi Z; Abdipour Mehrian SR; Bazrafshan Drissi H; Rahimian Z; Taherifard E; Nabavizadeh A; Kamalipour A; Mesgarpour B; Malekzadeh F; Molavi Vardanjani H
    BMC Cardiovasc Disord; 2022 Oct; 22(1):435. PubMed ID: 36203125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, Pattern, and Correlates of Polypharmacy among Iranian Type II Diabetic Patients: Results from Pars Cohort Study.
    Azadi M; Kamalipour A; Molavi Vardanjani H; Poustchi H; Taherifard E; Sharifi MH; Salehi A; Mohammadi Z
    Arch Iran Med; 2021 Sep; 24(9):657-664. PubMed ID: 34816680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy and pattern of medication use among patients with gastroesophageal reflux disease: results from Pars Cohort study.
    Ghamar-Shooshtari A; Rahimian Z; Poustchi H; Mohammadi Z; Mesgarpour B; Akbari M; Kamalipour A; Abdipour-Mehrian SR; Hashemi ES; Zare P; Lankarani KB; Malekzadeh R; Malekzadeh F; Vardanjani HM
    BMC Gastroenterol; 2023 Dec; 23(1):439. PubMed ID: 38097949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study.
    Akbari MR; Kamalipour A; Pakroo M; Mesgarpour B; Poustchi H; Mohammadi Z; Gandomkar A; Molavi Vardanjani H
    Arch Iran Med; 2023 Mar; 26(3):156-165. PubMed ID: 37543938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross-sectional study.
    Taherifard E; Mohammadi Z; Molavi Vardanjani H; Pakroo M; Emaminia M; Rahimi Z; Danehchin L; Abolnezhadian F; Malihi R; Paridar Y; Hariri S; Hashemi F; Cheraghian B; Mard A; Shayesteh AA; Poustchi H
    Pharmacoepidemiol Drug Saf; 2022 May; 31(5):592-603. PubMed ID: 35187734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study.
    Ghaed-Sharaf M; Hariri S; Poustchi H; Nourollahi M; Khani S; Taherifard E; Mohammadi Z; Hadipour M; Sabaei R; Gandomkar A; Malekzadeh F; Vardanjani HM
    BMC Psychol; 2022 Jan; 10(1):12. PubMed ID: 35042543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).
    Vidoni ED; Kamat A; Gahan WP; Ourso V; Woodard K; Kerwin DR; Binder EF; Burns JM; Cullum M; Hynan LS; Vongpatanasin W; Zhu DC; Zhang R; Keller JN
    J Alzheimers Dis; 2020; 77(1):175-182. PubMed ID: 32716358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication utilization patterns in patients with post-COVID syndrome (PCS): Implications for polypharmacy and drug-drug interactions.
    Michael HU; Brouillette MJ; Fellows LK; Mayo NE
    J Am Pharm Assoc (2003); 2024; 64(4):102083. PubMed ID: 38574993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran.
    Amini A; Taherifard E; Akbari M; Taherifard E; Dehdari Ebrahimi N; Rajabi MR; Zamani F; Rekabpour SJ; Jafaraghaie R; Hassanzadeh J; Molavi Vardanjani H
    Expert Rev Hematol; 2024 Sep; 17(9):643-650. PubMed ID: 39061121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially inappropriate medication use among hypertensive older African-American adults.
    Bazargan M; Smith JL; King EO
    BMC Geriatr; 2018 Oct; 18(1):238. PubMed ID: 30290768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-adherence to antihypertensive medication: The role of mental and physical comorbidity.
    Calderón-Larrañaga A; Diaz E; Poblador-Plou B; Gimeno-Feliu LA; Abad-Díez JM; Prados-Torres A
    Int J Cardiol; 2016 Mar; 207():310-6. PubMed ID: 26814635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management Practices in Indian Patients with Uncontrolled Hypertension.
    Bharatia R; Chitale M; Saxena GN; Kumar RG; Chikkalingaiah ; Trailokya A; Dalvi K; Talele S
    J Assoc Physicians India; 2016 Jul; 64(7):14-21. PubMed ID: 27759337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
    Hwang AY; Dave CV; Smith SM
    Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
    Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G
    BMC Geriatr; 2018 Apr; 18(1):99. PubMed ID: 29678160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between polypharmacy and treatment intensity for hypertension and diabetes: a cross-sectional study of nursing home patients in British Columbia, Canada.
    McCracken R; McCormack J; McGregor MJ; Wong ST; Garrison S
    BMJ Open; 2017 Aug; 7(8):e017430. PubMed ID: 28801438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.
    Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases.
    Araújo LU; Santos DF; Bodevan EC; Cruz HLD; Souza J; Silva-Barcellos NM
    Rev Lat Am Enfermagem; 2019; 27():e3217. PubMed ID: 31826159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension medication from guidelines to practice: A cohort study in western Iran.
    Shahbazi F; Najafi F; Shojaei L; Farzaei MH; Shokoohinia Y; Pasdar Y; Hamzeh B; Tahvilian R; Rahimi W; Shakiba E; Karim H; Dobson A; Bhatt N; Moradinazar M
    Pharmacoepidemiol Drug Saf; 2023 Sep; 32(9):951-960. PubMed ID: 36974582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran.
    Najafipour H; Nasri HR; Afshari M; Moazenzadeh M; Shokoohi M; Foroud A; Etemad K; Sadeghi B; Mirzazadeh A
    Int J Public Health; 2014 Dec; 59(6):999-1009. PubMed ID: 25227395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.